Monaco Asset Management SAM

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1803593 Monaco, O9

Position in HRTX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$686,497

-$916,431 QoQ

Shares Held

858,122

-30.4% QoQ

Ownership

0.452%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc.	2,231,026	$13,921,602
2	BMRN	Biomarin Pharmaceutical Inc	184,937	$10,582,095
3	RCKT	Rocket Pharmaceuticals, Inc.	2,480,468	$8,483,200
4	NKTX	Nkarta, Inc.	2,373,400	$6,716,722
5	NVAX	Novavax Inc	577,464	$5,439,710
6	PLRX	Pliant Therapeutics, Inc.	1,938,747	$2,210,171
7	VNDA	Vanda Pharmaceuticals Inc.	221,286	$1,354,270
8	LKFT	Lakefront Biotherapeutics NV	25,600	$767,488

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$686,497	858,122	-30.4%	Shares	Sole	2026-05-11
2025-12-31	$1,602,928	1,233,022	+23.0%	Shares	Sole	2026-02-10
2025-09-30	$1,263,119	1,002,476	-7.2%	Shares	Sole	2025-11-10
2025-06-30	$2,235,600	1,080,000	+12.5%	Shares	Sole	2025-08-07
2025-03-31	$2,112,000	960,000	-20.8%	Shares	Sole	2025-05-08
2024-12-31	$1,855,496	1,212,743	-27.7%	Shares	Sole	2025-02-10
2024-09-30	$3,340,049	1,678,417	+10.9%	Shares	Sole	2024-11-07
2024-06-30	$5,296,074	1,513,164	-16.5%	Shares	Sole	2024-08-07
2024-03-31	$5,022,464	1,813,164	-18.6%	Shares	Sole	2024-05-09
2023-12-31	$3,785,007	2,226,475	+219.5%	Shares	Sole	2024-02-07
2023-09-30	$717,815	696,908	+72.1%	Shares	Sole	2023-11-07
2023-06-30	$469,800	405,000	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.